Overview

DC Vaccine in Pancreatic Cancer

Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This research study is designed to evaluate the effects of a dendritic cell (kind of white blood cell) vaccine for pancreatic cancer.
Phase:
Phase 1
Details
Lead Sponsor:
University of Pennsylvania
Treatments:
Vaccines